由于新药上市前临床试验存在许多局限性，故上市后药品再评价非常重要。
The re-evaluation of the effectiveness of new drugs is of great importance when they are in post-market for there exist some limitations in clinical trials before these drugs are put on the market.
但基于前临床试验结果和研究结果表现出的良好前景，研究者们仍然相信这种治疗程序会成为未来病人们的一个现实的选择。
But based on promising results in preclinical trials and the results of the study, researchers still believe the procedure may be a realistic option for other patients in the future.
在研究方面，为潜在的治疗药物展开昂贵的临床试验前，它能帮助分析。
On the research side, it will help with the analysis of potential drugs before they are deployed in costly clinical trials.
应用推荐